NEW YORK (GenomeWeb News) – Bruker today reported that revenues for its second quarter increased 5 percent year over year as the company missed the consensus Wall Street estimate on the top and bottom line.

For the three months ended June 30, Bruker posted revenues of $420.7 million, up from the year-ago figure of $401.2 million, but short of the average analyst estimate of $425 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.